TRISPORT PHARMA
0433.713.130 · rovalta.com · 24/09/2026
TRISPORT PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOTRISPORT PHARMA is a Private company with limited liability incorporated in 1988. Its main activity is: Manufacture of homogenised food preparations and dietetic food. Its registered office is in Beernem.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0433.713.130
- Incorporation
- 18/03/1988
- Legal form
- Private company with limited liability
- Registered office
- Gevaerts-Noord 4
8730 Beernem · FlandreSee on map - Contributed capital
- 48 339,24 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 17,5 k € | +368% | -6,5 k € | +35.7% | -10,2 k € | +53.5% | -21,8 k € | -201% | 21,5 k € |
| EBITDA | 16,7 k € | +332% | -7,2 k € | +35.8% | -11,2 k € | +51.3% | -23 k € | -224% | 18,5 k € |
| Operating result | 16,7 k € | +332% | -7,2 k € | +35.8% | -11,2 k € | +51.3% | -23 k € | -224% | 18,5 k € |
| Net result | 21,7 k € | +273% | -12,6 k € | -4.1% | -12,1 k € | +45.9% | -22,3 k € | -231% | 17 k € |
| Balance sheet | |||||||||
| Equity | 11,5 k € | +213% | -10,2 k € | -529% | 2,4 k € | -83.6% | 14,4 k € | -60.7% | 36,7 k € |
| Total assets | 86,3 k € | +5.7% | 81,6 k € | -7.7% | 88,5 k € | -6.6% | 94,8 k € | -20.8% | 119,8 k € |
| Cash | 13,3 k € | -49.2% | 26,2 k € | +220% | 8,2 k € | -37.6% | 13,1 k € | -51.9% | 27,2 k € |
| Debts | 74,8 k € | -18.5% | 91,8 k € | +6.6% | 86,1 k € | +7.2% | 80,4 k € | -3.2% | 83 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 11 ended
Active mandates
Ended mandates
Other companies at this address
Gevaerts-Noord 4 8730 Beernem| Company | CBE no. |
|---|---|
Bloemeghem● Active | 0838.474.037 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/08/2026 | 23/07/2025 | 30/08/2024 | 25/09/2023 | 31/08/2022 | 31/08/2021 |
| General meeting | 30/06/2026 | 16/05/2025 | 30/06/2024 | 30/08/2023 | 10/08/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 26/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 16/05/2025 | 23/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 30/06/2024 | 30/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/08/2023 | 25/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 10/08/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/06/2021 | 31/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 10/08/2020 | 11/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 28/06/2019 | 30/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 30/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 01/06/2017 | 21/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/05/2016 | 24/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 30/06/2015 | 06/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 16/05/2014 | 14/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 17/05/2013 | 28/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 18/05/2012 | 20/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 20/05/2011 | 22/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 21/05/2010 | 25/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 15/05/2009 | 03/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 16/05/2008 | 07/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 18/05/2007 | 15/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 11 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office07/04/2017MAATSCHAPPELIJKE ZETEL
- Mandates19/05/2014KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates02/04/2013MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Other04/12/2009BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates09/09/2009ONTSLAGEN - BENOEMINGEN
- Mandates22/04/2008ONTSLAGEN - BENOEMINGEN
- Registered office05/10/2006ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - MAATSCHAPPELIJKE ZETEL
- Mandates02/03/2005MAATSCHAPPELIJKE ZETEL - BENAMING - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202521,7 k €↑
- 2024Annual accounts 2024-12,6 k €↓
- 2023Annual accounts 2023-12,1 k €↑
- 2022Annual accounts 2022-22,3 k €↓
- 2021Annual accounts 202117 k €↑
- 2020Annual accounts 2020-4,2 k €↑
- 2019Annual accounts 2019-29,9 k €↓
- 2018Annual accounts 20183,2 k €↑
- 2017Annual accounts 2017-833,4 €↓
- 2016Annual accounts 2016-239,6 €↑
- 2015Annual accounts 2015-862,1 €↓
- 2014Annual accounts 20149,1 k €↑
- 2013Annual accounts 2013-13,3 k €↓
- 2012Annual accounts 20121,2 k €↓
- 2011Annual accounts 20118,7 k €↑
- 2010Annual accounts 2010-1,8 k €↓
- 2009Annual accounts 200910,3 k €↑
- 2009Name changeTrisport-Pharma
- 2008Annual accounts 2008-16,2 k €↓
- 2007Annual accounts 200718,5 k €↑
- 2006Annual accounts 200615,5 k €
- 2006Name changeTRIMEDICO
- 18/03/1988IncorporationPrivate company with limited liability